![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: BDP1 |
Gene summary for BDP1 |
![]() |
Gene information | Species | Human | Gene symbol | BDP1 | Gene ID | 55814 |
Gene name | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | |
Gene Alias | DFNB112 | |
Cytomap | 5q13.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | A6H8Y1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55814 | BDP1 | CCI_2 | Human | Cervix | CC | 4.25e-06 | 7.85e-01 | 0.5249 |
55814 | BDP1 | CCI_3 | Human | Cervix | CC | 1.85e-02 | 5.13e-01 | 0.516 |
55814 | BDP1 | Tumor | Human | Cervix | CC | 1.55e-04 | -3.08e-01 | 0.1241 |
55814 | BDP1 | sample3 | Human | Cervix | CC | 4.83e-04 | -2.44e-01 | 0.1387 |
55814 | BDP1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.29e-09 | -5.38e-01 | 0.0155 |
55814 | BDP1 | HTA11_3361_2000001011 | Human | Colorectum | AD | 9.48e-03 | -5.48e-01 | -0.1207 |
55814 | BDP1 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 5.12e-06 | -3.83e-01 | 0.294 |
55814 | BDP1 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 7.12e-04 | -3.18e-01 | 0.3859 |
55814 | BDP1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 8.16e-07 | -4.36e-01 | 0.3005 |
55814 | BDP1 | A002-C-010 | Human | Colorectum | FAP | 3.57e-04 | -6.49e-02 | 0.242 |
55814 | BDP1 | A015-C-203 | Human | Colorectum | FAP | 1.36e-26 | 1.26e-01 | -0.1294 |
55814 | BDP1 | A015-C-204 | Human | Colorectum | FAP | 4.95e-06 | 2.25e-01 | -0.0228 |
55814 | BDP1 | A014-C-040 | Human | Colorectum | FAP | 3.17e-02 | 6.32e-02 | -0.1184 |
55814 | BDP1 | A002-C-201 | Human | Colorectum | FAP | 4.19e-09 | 4.87e-02 | 0.0324 |
55814 | BDP1 | A001-C-119 | Human | Colorectum | FAP | 4.62e-26 | 6.11e-01 | -0.1557 |
55814 | BDP1 | A001-C-108 | Human | Colorectum | FAP | 4.02e-22 | 3.84e-01 | -0.0272 |
55814 | BDP1 | A002-C-021 | Human | Colorectum | FAP | 3.25e-02 | 3.17e-01 | 0.1171 |
55814 | BDP1 | A002-C-205 | Human | Colorectum | FAP | 1.57e-40 | 6.20e-01 | -0.1236 |
55814 | BDP1 | A014-C-108 | Human | Colorectum | FAP | 4.62e-06 | 3.94e-01 | -0.124 |
55814 | BDP1 | A001-C-104 | Human | Colorectum | FAP | 1.02e-10 | 4.22e-01 | 0.0184 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00063833 | Esophagus | ESCC | transcription by RNA polymerase III | 41/8552 | 46/18723 | 7.69e-10 | 1.90e-08 | 41 |
GO:000635211 | Esophagus | ESCC | DNA-templated transcription, initiation | 86/8552 | 130/18723 | 1.88e-06 | 2.19e-05 | 86 |
GO:00708973 | Esophagus | ESCC | transcription preinitiation complex assembly | 30/8552 | 36/18723 | 3.60e-06 | 3.95e-05 | 30 |
GO:0070897 | Liver | Cirrhotic | transcription preinitiation complex assembly | 17/4634 | 36/18723 | 2.82e-03 | 1.63e-02 | 17 |
GO:0006352 | Liver | HCC | DNA-templated transcription, initiation | 78/7958 | 130/18723 | 4.19e-05 | 4.11e-04 | 78 |
GO:0006383 | Liver | HCC | transcription by RNA polymerase III | 31/7958 | 46/18723 | 5.67e-04 | 3.61e-03 | 31 |
GO:00708971 | Liver | HCC | transcription preinitiation complex assembly | 25/7958 | 36/18723 | 9.87e-04 | 5.71e-03 | 25 |
GO:00063832 | Oral cavity | OSCC | transcription by RNA polymerase III | 34/7305 | 46/18723 | 1.61e-06 | 2.11e-05 | 34 |
GO:00063522 | Oral cavity | OSCC | DNA-templated transcription, initiation | 74/7305 | 130/18723 | 2.56e-05 | 2.39e-04 | 74 |
GO:00708972 | Oral cavity | OSCC | transcription preinitiation complex assembly | 24/7305 | 36/18723 | 7.18e-04 | 3.95e-03 | 24 |
GO:0071824 | Skin | AK | protein-DNA complex subunit organization | 38/1910 | 241/18723 | 4.43e-03 | 2.57e-02 | 38 |
GO:00063524 | Skin | AK | DNA-templated transcription, initiation | 23/1910 | 130/18723 | 6.10e-03 | 3.29e-02 | 23 |
GO:000635212 | Skin | cSCC | DNA-templated transcription, initiation | 57/4864 | 130/18723 | 7.28e-06 | 1.01e-04 | 57 |
GO:00708974 | Skin | cSCC | transcription preinitiation complex assembly | 21/4864 | 36/18723 | 3.98e-05 | 4.26e-04 | 21 |
GO:00718241 | Skin | cSCC | protein-DNA complex subunit organization | 87/4864 | 241/18723 | 3.09e-04 | 2.47e-03 | 87 |
GO:00063834 | Skin | cSCC | transcription by RNA polymerase III | 20/4864 | 46/18723 | 7.44e-03 | 3.50e-02 | 20 |
GO:00063525 | Thyroid | PTC | DNA-templated transcription, initiation | 63/5968 | 130/18723 | 5.72e-05 | 5.05e-04 | 63 |
GO:00708975 | Thyroid | PTC | transcription preinitiation complex assembly | 22/5968 | 36/18723 | 2.85e-04 | 2.02e-03 | 22 |
GO:00063835 | Thyroid | PTC | transcription by RNA polymerase III | 23/5968 | 46/18723 | 7.89e-03 | 3.33e-02 | 23 |
GO:000635213 | Thyroid | ATC | DNA-templated transcription, initiation | 64/6293 | 130/18723 | 1.60e-04 | 1.10e-03 | 64 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
BDP1 | SNV | Missense_Mutation | c.1116N>T | p.Gln372His | p.Q372H | A6H8Y1 | protein_coding | deleterious(0) | probably_damaging(0.968) | TCGA-44-8117-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
BDP1 | SNV | Missense_Mutation | c.2642N>T | p.Ala881Val | p.A881V | A6H8Y1 | protein_coding | tolerated(0.1) | benign(0.143) | TCGA-44-8117-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
BDP1 | SNV | Missense_Mutation | c.3183N>T | p.Glu1061Asp | p.E1061D | A6H8Y1 | protein_coding | tolerated(0.15) | benign(0.006) | TCGA-50-5941-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Unspecific | Cisplatin | Complete Response | |
BDP1 | SNV | Missense_Mutation | novel | c.347A>C | p.His116Pro | p.H116P | A6H8Y1 | protein_coding | tolerated(0.12) | benign(0.007) | TCGA-55-1592-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
BDP1 | SNV | Missense_Mutation | c.3452G>C | p.Arg1151Thr | p.R1151T | A6H8Y1 | protein_coding | tolerated(0.06) | possibly_damaging(0.565) | TCGA-55-6972-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
BDP1 | SNV | Missense_Mutation | novel | c.2878A>T | p.Thr960Ser | p.T960S | A6H8Y1 | protein_coding | tolerated(0.05) | benign(0.015) | TCGA-55-7574-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | PD |
BDP1 | SNV | Missense_Mutation | novel | c.1229G>T | p.Cys410Phe | p.C410F | A6H8Y1 | protein_coding | deleterious(0) | benign(0.131) | TCGA-55-7910-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
BDP1 | SNV | Missense_Mutation | novel | c.1271N>C | p.Arg424Thr | p.R424T | A6H8Y1 | protein_coding | tolerated(0.1) | benign(0.069) | TCGA-55-8089-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
BDP1 | SNV | Missense_Mutation | c.2536N>T | p.Ala846Ser | p.A846S | A6H8Y1 | protein_coding | tolerated(0.32) | benign(0.022) | TCGA-55-8302-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
BDP1 | SNV | Missense_Mutation | c.2749N>C | p.Glu917Gln | p.E917Q | A6H8Y1 | protein_coding | tolerated(0.16) | possibly_damaging(0.848) | TCGA-55-A48Z-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |